Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal ...

WASHINGTON -- A dual intervention using lactulose and virtual tai chi significantly reduced falls and related harms in ...

Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...

Portal hypertension occurs when the portal vein that carries blood from the digestive organs to the liver is blocked, causing increased pressure. This increased pressure then causes varices to appear ...

Patients with nonalcoholic fatty liver disease often had indications of portal hypertension and esophageal varices, most commonly among those with advanced fibrosis, in a recent study. Researchers ...

The hepatic venous pressure gradient is not reduced, and fluid retention persists across several different doses of zibotentan with dapagliflozin.

Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver perfusion ...

A physician-scientist at UT Southwestern Medical Center and his research team have identified mechanisms causing a potentially deadly type of hypertension that results from liver damage -- findings ...

January 29, 2010 — Didanosine (Videc, VidecEC, Bristol Myers-Squibb) is associated with noncirrhotic portal hypertension, and as a result the label is being updated to include this information, the US ...

The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PH Lanifibranor was observed to decrease portal pressure by ...

In a new study, a therapeutic agent called sorafenib dramatically improved the condition of rats with portal hypertension. The drug is already approved in several countries for treatment of kidney and ...